News
The trends on Gift Nifty also indicate a negative start for the Indian benchmark index. The Gift Nifty was trading around ...
BofA Global Research Remains Positive on Vedanta Amid Improving Credit Profile, Attractive Valuation
BofA Global Research maintains a positive view on Vedanta, highlighting its improving credit profile, strong fundamentals, ...
LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...
FDA Protocol Review Completed ~~ Rho, Inc. Selected as Clinical Research Partner ~ SAN DIEGO, CA / ACCESS Newswire / July 16, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company" ...
1h
Zacks Investment Research on MSN3 American Century Mutual Funds to Navigate Market VolatilityFounded in 1958 by James E. Stowers Jr., American Century Investments is headquartered in Kansas City, MO, and managed around $268 billion in assets as of March 2025. American Century Mutual Funds ...
Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...
Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.
According to weekly options data, the Nifty 50 is likely to trade in the 25,000–25,500 range in the short term, with a decisive move on either side likely to determine the next directional trend.
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...
On Tuesday, 15 July, the Indian stock market showed remarkable resilience as it clawed back intraday losses to close on a ...
M&M, Wipro, Tech Mahindra, Nestle, SBI and Infosys led the gainers of Nifty 50 pack. Lack of fresh triggers, mixed global ...
Interest rate cuts will be a strong tailwind for ultra-high-yield stocks, and four trading below $10 offer investors great ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results